Publications

This page features brochures, newsletters, white papers, videos, and other resources devoted to the latest scholarship in aging research, age-related diseases and conditions, and living healthier, longer. Many publications are also available in hard copy

Browse Publications


Featured Publication



Public Comments

AHRQ Submitted Comments on Key Questions for Stroke Prevention in Atrial Fibrillation

Date: October 4th, 2011

AHRQ Comments

Home > Aging Topics > Atrial Fibrillation > AHRQ Comments

October 14, 2011
Agency for Healthcare Research and Quality
Effective Health Care Program
Scientific Resource Center, Oregon EPC
Mail Code: BICC
3181 S.W. Sam Jackson Park Road
Portland, Oregon 97239-3098

RE: Comment on Key Questions for Stroke Prevention in Atrial Fibrillation

Dear Sir or Madam:

Thank you for the opportunity to comment on AHRQ’s key questions related to the Effective Health Care Program’s comparative effectiveness review of stroke prevention in atrial fibrillation. We believe this is an important time to review in light of the growing impact atrial fibrillation has on our aging population and the uncertainty that exists about the best way to treat older patients with the condition.



Public Comments

AHRQ Submitted Comments on Key Questions for Stroke Prevention in Atrial Fibrillation--2012

Date: September 28th, 2012

September 28, 2012

Agency for Health Research and Quality
Effective Health Care Program
Scientific Resource Center, Oregon EPC Mail code: BICC 3181 S.W. Sam Jackson Park Road Portland, Oregon 97239-3098
Re: Draft Report on Comparative Effectiveness Review (CER) of Stroke Prevention in Atrial
Fibrillation
 

Dear Sir or Madam,

Because of the growing impact atrial fibrillation (AFib) is having on our aging population, the AFib Optimal Treatment Task Force, comprised of 12 leading organizations in the thrombosis space, was formed in 2011 to raise awareness of the impact of the disease and to explore issues related to the process used by healthcare providers to assess stroke and bleeding risk in making decisions about anticoagulation therapy for older patients with AFib. We submitted comments to the Agency for Health Research and Quality (AHRQ) in October of 2011 on the importance of reviewing both stroke and bleeding risk assessment tools in the Effective Health Care Program’s comparative effectiveness study of stroke prevention in AFib, and we appreciate the opportunity to provide additional comments on the findings included in the draft report.



Public Comments

PCORI Submitted Comments on National Priorities for Research and Research Agenda

Date: March 5th, 2012

March 15, 2012

Joe V. Selby, M.D., M.P.H.
Executive Director
Patient Centered Outcomes Research Institute
1701 Pennsylvania Ave, NW Suite 300
Washington, D.C. 20006

RE: Comments on PCORI National Priorities for Research and Research Agenda

Dear Dr. Selby:

The groups below comprise a task force of leading organizations in the thrombosis space that are exploring issues related to optimal stroke prevention in atrial fibrillation. Participants in this task force represent various audiences—from patients to health care providers—that are unified by the desire to improve the way in which stroke and bleeding risk are assessed in atrial fibrillation patients and ensure proper treatment of these patients. In our capacity as health care stakeholders, we support the Patient Centered Outcomes Research Institute’s (PCORI) mission to improve health care delivery and outcomes by producing and promoting high integrity, evidence-based information that comes from research guided by patients, caregivers and the health care community. As such we appreciate the opportunity to comment on PCORI’s national research priorities and research agenda.



Public Comments

PQRS Submitted Comments on Proposed Rule for Revisions to the 2013 Medicare Physician Fee Schedule

Date: September 4th, 2012

September 4, 2012

Marilyn Tavenner
Acting Administrator
 Centers for Medicare & Medicaid Services
Department of Health and Human Services
Attn: CMS-1590-P P.O. Box 8013
Baltimore, MD 21244-8013

 RE: Comments on Proposed Rule for Revisions to the 2013 Medicare Physician Fee Schedule

Dear Administrator Tavenner:

Because of the growing impact atrial fibrillation (AFib) is having on our aging population, the AFib Optimal Treatment Task Force, comprised of 12 leading organizations in the thrombosis space, formed in 2011 to raise awareness of the impact of the disease and to explore issues related to the process used by healthcare providers to assess both stroke and bleeding risk in making decisions about anticoagulation therapy for patients with AFib. We appreciate the opportunity to comment on the Centers for Medicare & Medicaid Services’ (CMS) Proposed Rule for Revisions to the 2013 Medicare Physician Fee Schedule. Our comments on the proposed rule will be limited to a new measure #1525, Chronic Anticoagulation Therapy, which is under consideration by CMS for inclusion in the Physician Quality Reporting System (PQRS) for CY2013. Recent expert consensus led by the AFib Optimal Treatment Task Force supports the use of this measure but with an additional recommendation to encourage routine and proper bleeding risk assessment. We urge you to include a modified version of measure #1525 in the final rule that encourages a bleeding risk assessment in addition to a stroke risk assessment to ensure that Medicare beneficiaries with AFib are presented with all treatment options that may be available for them.



Survey

Pain Management Survey

Author: Clarus Research Group

Date: September 1st, 2009

The Alliance for Aging Research commissioned a nationwide survey of 800 U.S. adults age 65 and older to better understand their attitudes, perceptions and concerns regarding age-related pain management and changes under consideration by the FDA to over-the-counter acetaminophen products. Clarus Research Group conducted the survey on behalf of the Alliance for Aging Research between September 14 and September 18, 2009. Support for the survey was provided by McNeil Consumer Healthcare, Division of McNeil-PPC, Inc.












Public Comments

Protect Medical Innovation Act of 2015 Letter

Author: Cynthia Bens

Date: June 1st, 2015

The Alliance for Aging Research submitted a letter to the Committee on Ways and Means to advocate for the Protect Medical Innovation Act of 2015. The bill amends the Internal Revenue code to repeal the excise tax on medical device manufacturers and importers. 




Public Comments

Letter to Sen. Coons and Schatz Regarding OMB M 12 M Memo

Author: Various

Date: August 10th, 2015

This letter from a group of organizations including the Alliance thanks U.S. Sens Chris Coons and Brian Schatz for "championing the amendment to provide the Office of Management and Budget the flexibility to update its M-12-12 memo during the recent markup of the FY 2016 Financial Services and General Government Appropriations Act."






Public Comments

Medicare Part D Non-Interference Letter

Date: March 4th, 2015

The Alliance for Aging Research signed a letter expressing opposition to proposals that would allow the Secretary of Health and Human Services (HHS) to interfere in private prescription drug negotiations in the Medicare Part D program.




Public Comments

S-FAR's PATH Act Letter

Author: S-FAR

Date: February 23rd, 2016

The Alliance for Aging Research signed onto the U.S. Stakeholder Forum for Antibiotic Resistance (S-FAR) sign-on letter for the Senate HELP Committee, supporting S.185, the Promise for Antibiotics and Therapeutics for Health (PATH) Act. 



Public Comments

DefeatMalnutrition Letter

Author: DefeatMalnutrition

Date: November 13th, 2015

The Alliance for Aging Research signed on to a letter from the DefeatMalnutrition coalition, regarding the Department of Health and Human Services' (HHS) Healthy People 2020 Objectives. 



Public Comments

LCAO Older Americans Act Letter

Date: May 4th, 2015

The Alliance for Aging Research signed on to a letter in supporting S. 192, the bipartisan Older Americans Act of 2015, a bill that would ensure the important continuity of Older Americans Act (OAA) programs and services for three years. 



Public Comments

Coalition for Health Funding Letter

Author: Coalition for Health Funding

Date: February 22nd, 2016

The Alliance for Aging Research signed on to a Coalition for Health Funding letter in support of increasing the Departments of Labor, Health and Human Services, and Education and related agencies appropriations subcommittee, to increase the 302(b) allocations for the agencies under the subcommittee's jurisdiction. 



Public Comments

Government Employee Travel Restriction Letter

Author: AAAS

Date: April 21st, 2015

The Alliance for Aging Research signed on to a letter drafted by the American Association for the Advancement of Science (AAAS) expressing concern on the impact of the Administration's regulations and legislative initiatives related to restricting government employee travel to scientific conferences. 



Public Comments

FY16 Afib Appropriations Sign-On Letter

Date: March 27th, 2015

The Alliance for Aging Research signed onto a letter requesting the National Institute on Aging (NIA), National Heart, Lung, and Blood Institute (NHLBI), National Institute of Neurological Disorders and Stroke (NINDS), and other relevant NIH agencies, institutes, and offices provide technical assistance and otherwise support an effort to improve prevention of AFib-related stroke in older persons.



Living Longer & Loving It

Sign up for our electronic newsletter Living Longer & Loving It